Company news
Kintor Pharmaceutical Ltd news in 2022
Kintor Pharmaceutical Ltd's news releases, calls and decks from 2022, newest first.
Pharma Announced Completion of Phase I Trial of the World’s First PROTAC Compound (GT20029) for Topical Use
November 23, 2022
Kintor Pharmaceutical: Pharma Announces Oral Presentation at ASH 2022 Highlighting the Data from Novel Dual c-Myc/GSPT1 Degrader GT19715
November 9, 2022
Kintor Pharmaceutical: Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US
October 27, 2022
Kintor Pharmaceutical: Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Acne Vulgaris in China
October 16, 2022
Phase Ib Data of GT0918 for AR+ mBC Published in EJC
September 29, 2022
Kintor Pharmaceutical: Pharma Announces 2022 Interim Results and Recent Business Highlights
August 29, 2022
Kintor Pharmaceutical: Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US
August 3, 2022
Kintor Pharma Included in MSCI China Index
May 15, 2022
Kintor Pharmaceutical: Pharma Announces Two Upcoming Poster Presentations at AACR 2022
April 3, 2022